As we have previously highlighted, tau phosphorylation at the Ser262 site is intricately involved not only in the initiation of early tau lesions but also in the subsequent aggregation, seeding, and progression of AD pathology [80,81]. The gene discussed is MAPT; the disease is Alzheimer disease.